Repeated Dexamethasone Intravitreal Implant for the Treatment of Diabetic Macular Oedema Unresponsive to Anti-VEGF Therapy: Outcome and Predictive SD-OCT Features
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
Online-Ressource
- Language
-
Englisch
- Bibliographic citation
-
Repeated Dexamethasone Intravitreal Implant for the Treatment of Diabetic Macular Oedema Unresponsive to Anti-VEGF Therapy: Outcome and Predictive SD-OCT Features ; volume:239 ; number:4 ; year:2018 ; pages:205-214
Ophthalmologica ; 239, Heft 4 (2018), 205-214
- Creator
-
Hatz, Katja
Ebneter, Andreas
Tuerksever, Cengiz
Pruente, Christian
Zinkernagel, Martin
- DOI
-
10.1159/000485852
- URN
-
urn:nbn:de:101:1-2018060700282817072272
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:24 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Hatz, Katja
- Ebneter, Andreas
- Tuerksever, Cengiz
- Pruente, Christian
- Zinkernagel, Martin
Other Objects (12)
Comparison of the efficacy of intravitreal Anti-VEGF versus intravitreal dexamethasone implant in treatment resistant diabetic Macular Edema
Intravitreal dexamethasone implants versus intravitreal anti-VEGF treatment in treating patients with retinal vein occlusion: a meta-analysis
Guidance for anti-VEGF intravitreal injections during the COVID-19 pandemic
Case report: heart failure related to intravitreal injection of anti-VEGF
Bacterial endophthalmitis following anti-VEGF intravitreal injections: a retrospective case series
Hydrophilic Lens Opacification after Intravitreal Anti-VEGF Injections: A Case Series
Intravitreal anti-VEGF treatment for choroidal neovascularization secondary to traumatic choroidal rupture
Switch of intravitreal therapy for macular edema secondary to retinal vein occlusion from Anti-VEGF to dexamethasone implant and vice versa
Anti-VEGF : 13 tables
Estimation of the need for bilateral intravitreal anti-VEGF injections in clinical practice
Outcomes in diabetic macular edema switched directly or after a dexamethasone implant to a fluocinolone acetonide intravitreal implant following anti-VEGF treatment
Intravitreal Dexamethasone Implant in Patients Who Did Not Complete Anti-VEGF Loading Dose During the COVID-19 Pandemic: a Retrospective Observational Study
Comparison of the efficacy of intravitreal Anti-VEGF versus intravitreal dexamethasone implant in treatment resistant diabetic Macular Edema
Intravitreal dexamethasone implants versus intravitreal anti-VEGF treatment in treating patients with retinal vein occlusion: a meta-analysis
Guidance for anti-VEGF intravitreal injections during the COVID-19 pandemic
Case report: heart failure related to intravitreal injection of anti-VEGF
Bacterial endophthalmitis following anti-VEGF intravitreal injections: a retrospective case series
Hydrophilic Lens Opacification after Intravitreal Anti-VEGF Injections: A Case Series
Intravitreal anti-VEGF treatment for choroidal neovascularization secondary to traumatic choroidal rupture
Switch of intravitreal therapy for macular edema secondary to retinal vein occlusion from Anti-VEGF to dexamethasone implant and vice versa
Anti-VEGF : 13 tables
Estimation of the need for bilateral intravitreal anti-VEGF injections in clinical practice
Outcomes in diabetic macular edema switched directly or after a dexamethasone implant to a fluocinolone acetonide intravitreal implant following anti-VEGF treatment
Intravitreal Dexamethasone Implant in Patients Who Did Not Complete Anti-VEGF Loading Dose During the COVID-19 Pandemic: a Retrospective Observational Study
Comparison of the efficacy of intravitreal Anti-VEGF versus intravitreal dexamethasone implant in treatment resistant diabetic Macular Edema
Intravitreal dexamethasone implants versus intravitreal anti-VEGF treatment in treating patients with retinal vein occlusion: a meta-analysis
Guidance for anti-VEGF intravitreal injections during the COVID-19 pandemic
Case report: heart failure related to intravitreal injection of anti-VEGF
Bacterial endophthalmitis following anti-VEGF intravitreal injections: a retrospective case series
Hydrophilic Lens Opacification after Intravitreal Anti-VEGF Injections: A Case Series
Intravitreal anti-VEGF treatment for choroidal neovascularization secondary to traumatic choroidal rupture
Switch of intravitreal therapy for macular edema secondary to retinal vein occlusion from Anti-VEGF to dexamethasone implant and vice versa
Anti-VEGF : 13 tables
Estimation of the need for bilateral intravitreal anti-VEGF injections in clinical practice
Outcomes in diabetic macular edema switched directly or after a dexamethasone implant to a fluocinolone acetonide intravitreal implant following anti-VEGF treatment